华裔美国慢性鼻窦炎患者的治疗决策
这项前瞻性研究纳入134例药物难治性慢性鼻窦炎患者(29.1%为华裔美国人),其中79例(59.0%)选择接受内镜鼻窦手术。调整年龄、收入和SNOT-22评分后,非华裔美国人选择手术的倾向高于华裔美国人(OR=7.92;95%CI:2.95-21.28;p<0.001)。华裔美国人术后1个月和3个月SNOT-22评分较术前分别改善-11.29分和-16.29分,作者认为需进一步研究手术犹豫相关因素。
要点
- 134例药物难治性慢性鼻窦炎患者中59.0%选择内镜鼻窦手术。
- 调整混杂后非华裔美国人选择手术的OR为7.92(95%CI 2.95-21.28,p<0.001)。
- 华裔美国人术后1个月和3个月SNOT-22分别改善11.29分和16.29分。
核心结论
- 药物难治性慢性鼻窦炎的华裔美国人较非华裔美国人更少选择内镜鼻窦手术。
- 内镜鼻窦手术可改善华裔美国人慢性鼻窦炎患者以SNOT-22衡量的生活质量。
- 作者认为需进一步研究以识别导致手术犹豫的因素。
研究设计与样本
- 前瞻性研究,纳入既往药物治疗后症状持续的药物难治性慢性鼻窦炎患者。
- 患者选择继续药物治疗或接受内镜鼻窦手术以缓解症状。
- 共纳入134例患者,其中华裔美国人占29.1%。
- 采用双变量分析比较人口学与临床特征,采用多变量逻辑回归评估族裔与治疗方式选择的关联。
主要发现
- 134例患者中79例(59.0%)选择接受内镜鼻窦手术。
- 治疗组间在人口学特征、鼻息肉状态、合并症、SNOT-22评分、Lund-Mackay评分或改良Lund-Kennedy评分方面未见显著差异。
- 调整年龄、收入和SNOT-22评分后,非华裔美国人选择内镜鼻窦手术的倾向高于华裔美国人(OR=7.92;95%CI:2.95-21.28;p<0.001)。
- 接受内镜鼻窦手术的华裔美国患者术后1个月SNOT-22评分改善-11.29分,术后3个月改善-16.29分,均具临床意义。
局限性
- 作者在结论中提出需进一步研究以识别导致手术犹豫的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There has been limited research on the influence of race and ethnicity on treatment decision-making for chronic rhinosinusitis (CRS). This prospective study aims to investigate potential factors linked to treatment modality choice among patients with medically refractory CRS, distinguishing between Chinese American and non-Chinese American patients. METHODS: CRS patients with persistent symptoms despite prior medical treatment were prospectively enrolled. These patients chose either to continue medical treatment or to undergo endoscopic sinus surgery (ESS) to alleviate CRS symptoms. Demographic and clinical characteristics were compared using bivariate analysis. The association between ethnicity and treatment modality choice was assessed using multivariable logistic regression. RESULTS: Among the 134 patients (29.1% Chinese Americans) included, 79 patients (59.0%) elected to undergo ESS. No significant differences in demographics, nasal polyp status, comorbidities, Sinonasal Outcome Test (SNOT-22), Lund-Mackay, or modified Lund-Kennedy scores were found between the treatment groups. After adjusting for age, income, and SNOT-22 score, non-Chinese American patients were more inclined to select ESS (OR = 7.92; 95% CI: 2.95-21.28; p < 0.001) as opposed to Chinese American patients. Chinese American patients who underwent ESS had a clinically significant improvement in SNOT-22 scores at 1 month (-11.29 points) and 3 months (-16.29 points) postoperatively. CONCLUSIONS: Chinese American patients with refractory CRS are less likely to opt for ESS compared to non-Chinese American patients. Surgical treatment is effective in improving quality of life, as measured by the SNOT-22, among Chinese American CRS patients. Further investigations are warranted to identify factors contributing to surgical hesitancy. LEVEL OF EVIDENCE: 3 Laryngoscope, 135:1920-1927, 2025.
引用
- Hur K, Gao J, Adili A, et al. Treatment Decision-Making Among Chinese Americans With Chronic Rhinosinusitis. Laryngoscope. 2025. PMID: 39744809. doi:10.1002/lary.31982
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。